title: Keloids: what do we know and what do we do next?
authors.affiliation: Sunnybrook Research Institute, Toronto, Ontario, Canada.
authors.forename: Patrick H
authors.initials: PH
authors.lastname: Blit
authors.forename: Marc G
authors.initials: MG
authors.lastname: Jeschke
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000818:Animals; D043169:Endostatins / Q000378:metabolism* / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007627:Keloid / Q000188:drug therapy* / Q000378:metabolism*; D008297:Male; D009389:Neovascularization, Pathologic / Q000188:drug therapy* / Q000378:metabolism*; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism*
chemical_list: D020533:Angiogenesis Inhibitors; D043169:Endostatins; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A